Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.

DISCUSSION: Cell-free CMV remains a concern with current blood component processing as it passes through all the processes. However, since low levels of CMV DNA were identified in the donations tested, and no BMT recipients had TT-CMV, the residual threat of TT-CMV after leukocyte reduction appears to be very low.
PMID: 32203012 [PubMed - as supplied by publisher]

Source: Blood Transfusion - February 27, 2020 Category: Hematology Authors: Voruz S, Gowland P, Eyer C, Widmer N, Abonnenc M, Prudent M, Masouridi-Levrat S, Duchosal MA, Niederhauser C Tags: Blood Transfus Source Type: research